Le Lézard
Classified in: Health, Science and technology
Subject: MISCELLANEOUS

Terranueva Corporation to Begin Trading on the Canadian Securities Exchange


MONTREAL, Dec. 17, 2018 (GLOBE NEWSWIRE) -- TERRANUEVA CORPORATION ("Terranueva" or the "Company") announced that its common shares ("Common Shares") will be listed and begin trading today on the Canadian Securities Exchange (the "CSE") under the ticker symbol "TEQ". Terranueva Pharma is a private Québec-based Company operating in L'Assomption (Québec) that intends to become a major producer of cannabis.

"The listing of our Common Shares is an important milestone for Terranueva, providing us more credibility and access to capital. To achieve our goal, Terranueva is implementing a modular production approach incorporating the latest advances and innovations in process automation" said Pierre Ayotte, President and Chief Executive Officer of Terranueva. "We welcome new investors to take a closer look at the opportunities available to Terranueva Corporation".

A Listing Statement (Form 2A) with information about Terranueva prepared in accordance with the policies of the CSE has been filed on SEDAR at sedar.com. Terranueva recently completed a reverse takeover (RTO) of a Canadian public company, Axe Exploration Inc. which has been renamed Terranueva Corporation.

At the time of Listing, Terranueva has 31,663,293 Common Shares outstanding. Approximately 17,699,852 Common Shares are held by related persons or employees. The remaining 13,963,441 Common Shares are considered the public float.

Terranueva's Business

The Corporation aspires to be at the forefront of research and development focused on therapeutic cannabis treatments. The principle mission of Terranueva is to enhance the lives of those who experience chronic pain, migraines, sleeping disorders or anxiety, through innovative approaches to cannabis-related treatment. Terranueva's business vision is to produce cannabis to the highest standards in terms of effectiveness, quality and stability. As a technology driven company, we aim to develop the most sophisticated automated cannabis production system that will help to create traceability of our product and increase the yield of each of our strain to produce a premium quality product in the most efficient manner.

Learn more about Terranueva at terranueva.ca

CSE nor its regulation services provider (as that term is defined in its policies) accepts responsibility for the adequacy or accuracy of this news release.

For further information, please contact:

For Terranueva Corporation :

 
Pierre Monet, Chief Financial Officer
Telephone : (514) 883-8733

These press releases may also interest you

at 06:00
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...

at 06:00
65,000 Ontario hospital workers represented by the Ontario Council of Hospital Unions-CUPE (OCHU-CUPE) and SEIU Healthcare will see a 6% wage increase (3% wage increases in each of the next two years), improvements to health and dental benefits,...

at 05:29
SmartCella Holding AB today announces that Dr Ricardo Baptista has been appointed Chief Technology Officer (CTO) and Head of Procella. Ricardo is an experienced Biochemical Engineer with almost 20-years of global experience in the medical...

at 05:15
Every year in Quebec, more than 2,000 young people leave the care of the Director of Youth Protection (DYP) as they approach the age of majority. For youth under the care of the DYP, turning 18 means having to become independent quickly, with little...

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...



News published on and distributed by: